시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 이소소르비드 모노나이트레이트 정제 시장 보고서(2025년)
Isosorbide Mononitrate Tablet Global Market Report 2025
상품코드 : 1760582
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 175 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,516,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,419,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 12,322,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

이소소르비드 모노나이트레이트 정제 시장 규모는 향후 수년간 강력한 성장이 전망될 예정입니다. 예측 기간의 성장은 규제 승인 및 특허 만료, 제네릭 의약품의 채택 증가, 라이프스타일 관련 위험 요소의 증가, 심혈관 질환 관리를 위한 정부 이니셔티브, 진단 인프라 개선, 인식 캠페인에 기인할 수 있습니다. 이 기간의 주요 동향에는 서방형 제제의 진보, 기술 혁신, 디지털 헬스 플랫폼과 E-Commerce의 대두, 디지털 헬스 기술의 통합, 이소소르비드 모노나이트레이트와 다른 심혈관 치료제과의 병용 등이 있습니다.

심혈관질환(CVD)의 유병률 증가가 이소소르비드 모노나이트레이트 정제 시장의 성장을 견인하고 있습니다. 어떤 요인으로 만연하고 있어 비만, 고혈압, 고콜레스테롤 등의 증상의 일인이 되고 있습니다. 이로 인해 이러한 질병을 관리하는 데 일반적으로 사용되고 있습니다. 2021년 사망자 수는 1만 4,100명, 2022년에는 1만 4,900명으로 증가했습니다.

온라인 약국의 보급이, 이소소르비드 모노나이트레이트 정제 시장의 성장을 더욱 밀어주고 있습니다. Pharmacies(ASOP)가 2023년 9월에 실시한 조사에 의하면, 18세 이상의 미국인의 52%가 온라인 약국을 이용한 적이 있어, 이전보다 현저하게 증가하고 있는 것이 밝혀졌습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장의 거시경제 시나리오 : 금리, 인플레이션, 지정학, 무역 전쟁 및 관세, 코로나 및 회복이 시장에 미치는 영향을 포함

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 : 경쟁 벤치마킹 대시보드

제33장 주요 기업 합병 및 인수(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가 및 부문과 전략

제36장 부록

SHW
영문 목차

영문목차

Isosorbide mononitrate tablets are long-acting nitrate medications primarily used to prevent and control chest pain (angina) associated with coronary artery disease. The medication works by relaxing and dilating blood vessels, particularly in the heart, which allows for increased blood and oxygen flow while reducing the heart's workload. Unlike fast-acting nitrates used for immediate relief, isosorbide mononitrate is taken regularly as a maintenance therapy to reduce the frequency and severity of angina attacks and improve overall cardiovascular function.

The main dosage forms of isosorbide mononitrate tablets are immediate-release tablets and extended-release tablets. Immediate-release tablets are designed to dissolve quickly, allowing for rapid absorption and fast relief, especially for conditions such as angina. These tablets are used for various indications, including angina pectoris, heart failure, and hypertension, and are distributed through channels such as hospital pharmacies, retail pharmacies, and online pharmacies.

The isosorbide mononitrate tablet market research report is one of a series of new reports from The Business Research Company that provides isosorbide mononitrate tablet market statistics, including the isosorbide mononitrate tablet industry global market size, regional shares, competitors with the isosorbide mononitrate tablet market share, detailed isosorbide mononitrate tablet market segments, market trends, and opportunities, and any further data you may need to thrive in the isosorbide mononitrate tablet industry. This isosorbide mononitrate tablet market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The isosorbide mononitrate tablet market size has grown strongly in recent years. It will grow from$1.14 billion in 2024 to $1.21 billion in 2025 at a compound annual growth rate (CAGR) of 5.9%. The growth during the historic period can be attributed to the growing elderly population, the increasing incidence of heart-related conditions, greater awareness of heart health, the availability of generic drugs, and public health campaigns.

The isosorbide mononitrate tablet market size is expected to see strong growth in the next few years. It will grow to$1.51 billion in 2029 at a compound annual growth rate (CAGR) of 5.6%. The growth in the forecast period can be attributed to regulatory approvals and patent expirations, the increasing adoption of generic drugs, growth in lifestyle-related risk factors, government initiatives for cardiovascular disease management, improvements in diagnostic infrastructure, and awareness campaigns. Key trends during this period include advancements in extended-release formulations, technological innovations, the rise of digital health platforms and e-commerce, integration of digital health technologies, and the combination of isosorbide mononitrate with other cardiovascular drugs.

The increasing prevalence of cardiovascular diseases (CVDs) is driving the growth of the isosorbide mononitrate tablet market. CVDs, including coronary artery disease, heart failure, and hypertension, are becoming more widespread due to factors such as unhealthy diets high in saturated fats, trans fats, sodium, and added sugars, which contribute to conditions such as obesity, hypertension, and high cholesterol. Isosorbide mononitrate tablets are commonly used to manage these diseases by relaxing and widening blood vessels, which improves blood flow, reduces the heart's workload, and alleviates chest pain (angina). According to a report from the Australian Institute of Health and Welfare in December 2023, coronary heart disease (CHD) deaths in Australia have been increasing, with 14,100 deaths in 2021 rising to 14,900 in 2022. This growing prevalence of cardiovascular diseases is significantly contributing to the demand for effective treatments, such as isosorbide mononitrate tablets.

The increasing adoption of online pharmacies is further propelling the growth of the isosorbide mononitrate tablet market. Consumers are seeking greater convenience, affordability, and accessibility to medications without the need to visit physical pharmacies. Online pharmacies offer home delivery, competitive pricing, and improved availability, particularly for patients managing chronic conditions such as cardiovascular diseases. A survey conducted by the Alliance for Safe Online Pharmacies (ASOP) in September 2023 revealed that 52% of Americans aged 18 and older had used an online pharmacy, showing a notable increase from previous years. This surge in online pharmacy usage is making it easier for patients to access essential medications, including isosorbide mononitrate tablets, fueling market growth.

Pharmaceutical companies are focusing on the development of extended-release (ER) formulations of isosorbide mononitrate to improve patient compliance and enhance treatment outcomes. ER tablets provide sustained therapeutic effects by gradually releasing the medication over an extended period, reducing the need for frequent dosing and ensuring consistent blood levels of the drug. In February 2024, Zydus Lifesciences Limited received approval from the U.S. Food and Drug Administration (FDA) to market isosorbide mononitrate extended-release tablets in strengths of 30 mg, 60 mg, and 120 mg. These tablets help prevent chest pain (angina) in patients with coronary artery disease and offer a more convenient treatment option for those requiring long-term management, further contributing to the growth of the isosorbide mononitrate tablet market.

Major players in the isosorbide mononitrate tablet market are Pfizer Inc., Merck & Co. Inc., AstraZeneca PLC, Abbott Laboratories Inc., Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Ltd., Cipla Ltd., Zydus Lifesciences Limited, Recipeharm, Torrent Pharmaceuticals Ltd., Micro Labs Ltd., Lotus Pharmaceuticals, Healthy Inc., Qilu Pharmaceutical Co. Ltd, Lunan Pharmaceutical Group, Johnlee Pharmaceuticals Pvt. Ltd., Niksan Pharmaceutical, Shandong Keyuan Pharmaceutical, and Prevego Healthcare & Research Private Limited.

North America was the largest region in the isosorbide mononitrate tablet market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in isosorbide mononitrate tablet report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the isosorbide mononitrate tablet market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The isosorbide mononitrate tablet market consists of sales of dilatrate-SR, isochron, monoket, and imdur, pediatric and geriatric-adjusted tablets, and combination products. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Isosorbide Mononitrate Tablet Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on isosorbide mononitrate tablet market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for isosorbide mononitrate tablet ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The isosorbide mononitrate tablet market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Isosorbide Mononitrate Tablet Market Characteristics

3. Isosorbide Mononitrate Tablet Market Trends And Strategies

4. Isosorbide Mononitrate Tablet Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Isosorbide Mononitrate Tablet Growth Analysis And Strategic Analysis Framework

6. Isosorbide Mononitrate Tablet Market Segmentation

7. Isosorbide Mononitrate Tablet Market Regional And Country Analysis

8. Asia-Pacific Isosorbide Mononitrate Tablet Market

9. China Isosorbide Mononitrate Tablet Market

10. India Isosorbide Mononitrate Tablet Market

11. Japan Isosorbide Mononitrate Tablet Market

12. Australia Isosorbide Mononitrate Tablet Market

13. Indonesia Isosorbide Mononitrate Tablet Market

14. South Korea Isosorbide Mononitrate Tablet Market

15. Western Europe Isosorbide Mononitrate Tablet Market

16. UK Isosorbide Mononitrate Tablet Market

17. Germany Isosorbide Mononitrate Tablet Market

18. France Isosorbide Mononitrate Tablet Market

19. Italy Isosorbide Mononitrate Tablet Market

20. Spain Isosorbide Mononitrate Tablet Market

21. Eastern Europe Isosorbide Mononitrate Tablet Market

22. Russia Isosorbide Mononitrate Tablet Market

23. North America Isosorbide Mononitrate Tablet Market

24. USA Isosorbide Mononitrate Tablet Market

25. Canada Isosorbide Mononitrate Tablet Market

26. South America Isosorbide Mononitrate Tablet Market

27. Brazil Isosorbide Mononitrate Tablet Market

28. Middle East Isosorbide Mononitrate Tablet Market

29. Africa Isosorbide Mononitrate Tablet Market

30. Isosorbide Mononitrate Tablet Market Competitive Landscape And Company Profiles

31. Isosorbide Mononitrate Tablet Market Other Major And Innovative Companies

32. Global Isosorbide Mononitrate Tablet Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Isosorbide Mononitrate Tablet Market

34. Recent Developments In The Isosorbide Mononitrate Tablet Market

35. Isosorbide Mononitrate Tablet Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기